Cowen Prime Advisors LLC - HTG MOLECULAR DIAGNOSTICS IN ownership

Back to all holdings Add to watchlist

HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H203. A total of 24 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Cowen Prime Advisors LLC ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q1 2022$462,000
-85.6%
332,197
-44.0%
0.19%
-82.3%
Q4 2021$3,215,000
-19.4%
593,133
-15.1%
1.09%
-26.3%
Q3 2021$3,989,000
+20.4%
698,533
+22.5%
1.48%
+23.5%
Q2 2021$3,314,000–570,333–1.20%–
 Download
Other shareholders
HTG MOLECULAR DIAGNOSTICS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Virtu Financial LLC 72,452$44,0000.00%
HighMark Wealth Management LLC 6,966$4,0000.00%
UBS Group AG 26$00.00%
WELLS FARGO & COMPANY/MN 46$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 47,178$28,0000.00%
STATE STREET CORP 14,455$9,0000.00%
MILLENNIUM MANAGEMENT LLC 23,683$15,0000.00%
MORGAN STANLEY 10,611$7,0000.00%
BlackRock Inc. 74,192$45,0000.00%
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders